ES504682A0 - Procedimiento para la obtencion de derivados del 3-amino-1,2propandiol - Google Patents

Procedimiento para la obtencion de derivados del 3-amino-1,2propandiol

Info

Publication number
ES504682A0
ES504682A0 ES504682A ES504682A ES504682A0 ES 504682 A0 ES504682 A0 ES 504682A0 ES 504682 A ES504682 A ES 504682A ES 504682 A ES504682 A ES 504682A ES 504682 A0 ES504682 A0 ES 504682A0
Authority
ES
Spain
Prior art keywords
amino
procedure
obtaining derivatives
derivatives
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES504682A
Other languages
English (en)
Other versions
ES8301462A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES504682A0 publication Critical patent/ES504682A0/es
Publication of ES8301462A1 publication Critical patent/ES8301462A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES504682A 1980-08-13 1981-08-11 Procedimiento para la obtencion de derivados del 3-amino-1,2propandiol Expired ES8301462A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH611880 1980-08-13

Publications (2)

Publication Number Publication Date
ES504682A0 true ES504682A0 (es) 1982-12-01
ES8301462A1 ES8301462A1 (es) 1982-12-01

Family

ID=4304561

Family Applications (8)

Application Number Title Priority Date Filing Date
ES504682A Expired ES8301462A1 (es) 1980-08-13 1981-08-11 Procedimiento para la obtencion de derivados del 3-amino-1,2propandiol
ES514371A Expired ES8305694A1 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, s-propandiol
ES514365A Expired ES8305689A1 (es) 1980-08-13 1982-07-26 Procedimiento para obtencion de derivados del 3-amino-1,2- propandiol.
ES514368A Granted ES514368A0 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, 2-propandiol
ES514370A Granted ES514370A0 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1 2-propandiol
ES514369A Expired ES8305693A1 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, 2-propandiol
ES514367A Granted ES514367A0 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, 2-propandiol
ES514366A Expired ES8305690A1 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1,2-propandiol.

Family Applications After (7)

Application Number Title Priority Date Filing Date
ES514371A Expired ES8305694A1 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, s-propandiol
ES514365A Expired ES8305689A1 (es) 1980-08-13 1982-07-26 Procedimiento para obtencion de derivados del 3-amino-1,2- propandiol.
ES514368A Granted ES514368A0 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, 2-propandiol
ES514370A Granted ES514370A0 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1 2-propandiol
ES514369A Expired ES8305693A1 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, 2-propandiol
ES514367A Granted ES514367A0 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1, 2-propandiol
ES514366A Expired ES8305690A1 (es) 1980-08-13 1982-07-26 Procedimiento para la obtencion de derivados del 3-amino-1,2-propandiol.

Country Status (17)

Country Link
EP (1) EP0045964A1 (es)
JP (1) JPS5759842A (es)
KR (1) KR840002266B1 (es)
AR (6) AR231273A1 (es)
AU (1) AU543647B2 (es)
CA (1) CA1192221A (es)
DD (3) DD202691A5 (es)
DK (1) DK358381A (es)
ES (8) ES8301462A1 (es)
FI (1) FI812465L (es)
GR (1) GR74992B (es)
HU (1) HU186342B (es)
IL (1) IL63539A (es)
NO (1) NO812736L (es)
NZ (1) NZ198020A (es)
PT (1) PT73511B (es)
ZA (1) ZA815554B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58417B1 (en) * 1984-04-27 1993-09-22 Ici Plc Chemical derivatives
GB201101959D0 (en) * 2011-02-04 2011-03-23 Univ Nottingham Novel ether linked compoundsand improved treatments for cardiac and cardiovascular disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1398738A (en) * 1972-12-05 1975-06-25 Pfizer Ltd Propanolamine derivatives
DD144050A5 (de) * 1978-06-05 1980-09-24 Ciba Geigy Ag Verfahren zur herstellung von n-alkylierten aminoalkoholen
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols

Also Published As

Publication number Publication date
AR231278A1 (es) 1984-10-31
DD202691A5 (de) 1983-09-28
ES514369A0 (es) 1983-05-01
IL63539A0 (en) 1981-11-30
ES514366A0 (es) 1983-05-01
DD202532A5 (de) 1983-09-21
ES514365A0 (es) 1983-04-16
ES8305692A1 (es) 1983-05-01
ES8306473A1 (es) 1983-06-01
KR830006173A (ko) 1983-09-17
FI812465L (fi) 1982-02-14
AU543647B2 (en) 1985-04-26
ES514371A0 (es) 1983-05-01
EP0045964A1 (de) 1982-02-17
AR231631A1 (es) 1985-01-31
AR231274A1 (es) 1984-10-31
DK358381A (da) 1982-02-14
GR74992B (es) 1984-07-12
AU7402081A (en) 1982-02-18
DD202286A5 (de) 1983-09-07
ES8305691A1 (es) 1983-04-16
ES8305689A1 (es) 1983-04-16
KR840002266B1 (ko) 1984-12-14
ES514367A0 (es) 1983-04-16
PT73511A (en) 1981-09-01
HU186342B (en) 1985-07-29
NZ198020A (en) 1985-04-30
ES514368A0 (es) 1983-05-01
ES8305693A1 (es) 1983-05-01
AR231275A1 (es) 1984-10-31
AR229188A1 (es) 1983-06-30
PT73511B (en) 1983-07-06
ES8305690A1 (es) 1983-05-01
AR231273A1 (es) 1984-10-31
NO812736L (no) 1982-02-15
ES8305694A1 (es) 1983-05-01
ES514370A0 (es) 1983-06-01
IL63539A (en) 1984-11-30
JPS5759842A (en) 1982-04-10
CA1192221A (en) 1985-08-20
ES8301462A1 (es) 1982-12-01
ZA815554B (en) 1982-08-25

Similar Documents

Publication Publication Date Title
ES504694A0 (es) Procedimiento para la preparacion de derivados del indol.
ES504256A0 (es) Procedimiento para la obtencion de derivados de triazolil- propenol
ES522786A0 (es) Procedimiento para preparar derivados de piperacina.
AR231447A1 (es) Procedimiento para preparar derivados de 4,5-dihidro-imidazo 1,2-a-quinazolin-2 1h-ona
ES499834A0 (es) Procedimiento para la obtencion de nuevos derivados del aci-do lignosulfonicos
ES493068A0 (es) Procedimiento para la obtencion de derivados del amino-tia- diazolilo
ES513170A0 (es) Procedimiento para la obtencion de nuevos derivados del benzazol.
ES549384A0 (es) Procedimiento para la obtencion de derivados del 2-aminome- til-2-penem.
ES500892A0 (es) Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano
ES514479A0 (es) Procedimiento para la obtencion de derivados de diaril-imidazol.
ES515568A0 (es) Procedimiento para preparar derivados de fenantreno.
ES515767A0 (es) Procedimiento para preparar derivados de indano.
ES514371A0 (es) Procedimiento para la obtencion de derivados del 3-amino-1, s-propandiol
ES502909A0 (es) Procedimiento de preparar derivados de quinoxalina-1,4-dio- xido
ES504681A0 (es) Procedimiento para preparar derivados de 11- hidroxi-13 oxa-prostaglandina.
ES505441A0 (es) Procedimiento de preparacion de nuevos derivados 2-hidroxi- metil-quinoxalino-1,4-dioxidos
ES495153A0 (es) Procedimiento para la obtencion de derivados del decahidro- quinolinol
AR225532A1 (es) Procedimiento para preparar derivados de 20-dihidro-20,23-didesoxitilonolida
ES502681A0 (es) Procedimiento de preparar derivados metilquinoxalin-1-,4- dioxido
ES489076A0 (es) Procedimiento para la obtencion de derivados del difenilcar-binol
ES505442A0 (es) Procedimiento de preparacion de derivados 2-metileno-quino- xalino-1,4-dioxidos
ES516163A0 (es) Procedidmiento para la obtencion de nuevos derivados del naftaleno.
ES516162A0 (es) Procedimiento para la obtencion de nuevos derivados del naftaleno.
ES516160A0 (es) Procedimiento para la obtencion de nuevos derivados del naftaleno.
ES499545A0 (es) Procedimiento para preparar derivados de pirazol.